Trial
NCT02401594
PROphylaxis in NOn Major Orthopaedic Surgery
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
Bayer
Condition
Non-major Orthopaedic Surgery
Intervention
Rivaroxaban
Why stopped
Remaining outdated treatments and additional costs too high for new manufacturing
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-07